未登录

L

Laura Grant

adelphi values

H指数:13

被引数:877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lived experience of spontaneous preterm birth following spontaneous preterm labor: the primary caregiver’s perspective

Quality of Life Research

IF2.7

2026-01-090

OAAI

Development and Validation of a Patient-Reported Outcome Measure of the Impact of Chronic Hand Eczema on Health-Related Quality of Life: the Hand Eczema Impact Scale (HEIS)

DERMATOLOGY AND THERAPY

IF4.2

2024-10-211

OAAI

Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions

CONTACT DERMATITIS

IF4.6

2024-10-130

OAAI

Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD)

DERMATOLOGY AND THERAPY

IF4.2

2024-03-153

OAAI

Content validity of the EORTC quality of life questionnaire QLQ-C30 for use in cancer

EUROPEAN JOURNAL OF CANCER

IF7.1

2023-01-0143

OAAI

Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia

ADVANCES IN THERAPY

IF4

2021-10-277

OAAI

Development of a Conceptual Model of Chronic Hand Eczema (CHE) Based on Qualitative Interviews with Patients and Expert Dermatologists

ADVANCES IN THERAPY

IF4

2020-01-1923

OAAI

CURRENT CHALLENGES IN THE ASSESSMENT AND DIAGNOSIS OF OPTIC DISC SWELLING AND IDIOPATHIC INTRACRANIAL HYPERTENSION

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

IF7.5

2019-11-140

PRE

Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and Adolescents

IF3.2

2019-07-0132

OAAI

Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

ADVANCES IN THERAPY

IF4

2018-11-108

OAAI

PATIENT AND CAREGIVER WEB-BASED SURVEY: HEALTH UTILITIES IN TUBEROUS SCLEROSIS COMPLEX (TSC) PATIENT POPULATION

VALUE IN HEALTH

IF6

2018-10-013

OAAI

REVIEW OF FREQUENTLY IMPLEMENTED PATIENT REPORTED OUTCOMES IN CURRENT PROSTATE CANCER CLINICAL TRIALS

VALUE IN HEALTH

IF6

2018-05-010

OAAI

The power of support from companion animals for people living with mental health problems: a systematic review and narrative synthesis of the evidence

伴侣动物对有精神卫生问题的人的支持力量: 证据的系统回顾和叙事综合

IF3.6

2018-02-05227

OAAI

QUALITATIVE EXPLORATION OF THE REAL-WORLD EXPERIENCES OF MEN RECEIVING OR REFUSING CHEMOTHERAPY (DOCETAXEL) FOR THE TREATMENT OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

VALUE IN HEALTH

IF6

2017-10-010

OAAI

EVALUATING PATIENT REPORTED OUTCOMES COMMONLY USED IN CURRENT LUNG CANCER CLINICAL TRIALS

VALUE IN HEALTH

IF6

2017-10-010

OAAI

Content Validity of a Willingness to Quit Tool for Use with Current Smokers in Clinical Practice

ADVANCES IN THERAPY

IF4

2017-09-225

OAAI

Psychometric Validation of the Heart Failure Caregiver Questionnaire (HF-CQ®)

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

IF3.1

2017-03-2519

PREAI

Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

VALUE IN HEALTH

IF6

2017-03-018

OAAI

EXPLORING THE QUALITATIVE EXPERIENCE OF CHEST CONGESTION WITH CHILDREN AND ADULTS TO DEVELOP PATIENT-REPORTED OUTCOME ITEMS TO SELF-ASSESS SYMPTOMS OF THE COMMON COLD

VALUE IN HEALTH

IF6

2016-05-010

OAAI

Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

VALUE IN HEALTH

IF6

2015-12-019

PREAI